iTrack ab-interno canaloplasty
iTrack 02iTrack 03iTrack ab-interno canaloplasty

iTRACK™ ab-interno canaloplasty

  • Price: Contact
  • Brand: Nova Eye
  • Made In: USA

ITRACK™ IS THE WORLD’S FIRST CANALOPLASTY MICROCATHETER

Despite measuring just 250 microns – the equivalent of several strands of hair – the iTrack™ comprises an infusion pathway for the delivery of OVD and a proprietary guide-wire that controls how the microcatheter tracks and enables it to traverse the full 360° of the canal in a single intubation. It also features a fiber optic for illuminating the distal tip. Importantly, iTrack™ is the only canaloplasty microcatheter that enables you to customize the degree of viscodilation on an individual patient basis, maximizing patient outcomes.

Product Description

iTrack™ ab-interno canaloplasty is an implant-free, tissue-sparing MIGS procedure that achieves excellent clinical outcomes while also preserving the viability of future treatment options. Based on the same principles as angioplasty, iTrack™ combines 360° catheterization and pressurized viscodilation to remove all points of blockage in the proximal and distal outflow system – thereby reducing intraocular pressure (IOP) and patient dependence on medications.

  • Stent- and implant-free MIGS procedure
  • Tissue-sparing MIGS procedure
  • 30% average IOP reduction7,10,11
  • 50% average medication reduction 7,10,11
  • Minimal endothelial cell loss (-4.8%)12
  • Comprehensive — addresses all outflow pathway resistance points, including the collector channel ostia1,2
  • Excellent safety profile7 — overcomes the post-op complications seen with other MIGS such as stent misplacement and PAS3 – 6
  • Can be performed in conjunction with cataract surgery or as a standalone MIGS7,10,11

iTRACK™ CAN TREAT ALL SITES OF BLOCKAGE IN THE CONVENTIONAL OUTFLOW SYSTEM — AND REMOVES THE GUESSWORK INHERENT IN STENT-BASED MIGS

With iTrack™ ab-interno canaloplasty you can target and treat the trabecular meshwork, Schlemm’s canal and the collector channels. Not only does this comprehensively reduce IOP and the medication burden, but it removes the guesswork inherent in stent-based MIGS procedures.

TRABECULAR MESHWORK

50 – 75% of outflow resistance is localized within the trabecular meshwork.

iTrack™ separates trabecular plates within the trabecular meshwork.

 

SCHLEMM’S CANAL

The canal of a POAG patient tends to be shorter, more narrowed, and often collapsed.2

iTrack™ mechanically breaks adhesions within Schlemm’s canal and dilates Schlemm’s canal by up to 2 – 3 times via a process of pressurized viscodilation. 

+100 MICROLITERS OF OVD

iTrack™ delivers +100 microliters of OVD* over 360° of the canal to expand and dilate Schlemm’s canal, and to improve flow through to the episcleral venous system. As observed via blanching of the episcleral veins immediately following the procedure4, iTrack™ ab-interno canaloplasty improves flow through the entire conventional outflow system, including the distal portion.

Please contact us for order and/or more information:

Many thanks for your kind visit and consideration!

Related Products